Burning Rock Biotech: Leo Li, Xiaozhi Hu

Leo Li has resigned as CFO of Burning Rock Biotech and from its board, effective Sept. 27. The Guangzhou, China-based developer of next-generation sequencing-based cancer tests said Li's resignation was for personal reasons and did not result from any disagreement with the company or the board. Xiaozhi Hu, senior director of Burning Rock's board, will be in charge of its financial operations, financial reporting, and related matters of the firm, the company said.